Navigation Links
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
Date:12/10/2007

ressure.

LEVITRA is not recommended for patients with uncontrolled hypertension (>170/110 mmHg).

In men for whom sexual activity is not recommended because of their underlying cardiovascular status, any treatment for erectile dysfunction, including LEVITRA, generally should not be used.

In patients taking certain CYP3A4 inhibitors (eg, ritonavir, indinavir, saquinavir, atazanavir, ketoconazole, itraconazole, erythromycin, and clarithromycin), lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended. See prescribing information for LEVITRA for dosing guidance.

In clinical trials, the most commonly reported adverse events with LEVITRA were headache, flushing, and rhinitis. Adverse events were generally transient.

Nonarteritic anterior ischemic optic neuropathy (NAION) has been reported rarely postmarketing in temporal relationship with the use of PDE5 inhibitors, including LEVITRA. Sudden loss of hearing, sometimes with tinnitus and dizziness, also has been reported rarely in temporal association with the use of PDE5 inhibitors, including LEVITRA. It is not possible to determine if these events are related to PDE5 inhibitors or to other factors. Physicians should advise patients to stop use of PDE5 inhibitors, including LEVITRA, and seek prompt medical attention in the event of sudden loss of vision or hearing.

The recommended starting dose of LEVITRA is 10 mg. Titrate up to 20 mg or down to 5 mg based on efficacy and side effects.
The maximum recommended dosing frequency is once daily.

LEVITRA is available in 2.5-mg, 5-mg, 10-mg and 20-mg tablets.

For Prescribing Information please visit http://www.levitra.com.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling peop
'/>"/>

SOURCE Schering-Plough
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... Berger & Montague, P.C., a full-spectrum ... with one of the largest and most successful ... and Faruqi, LLP in settling three separate but ... LP, Cephalon, Inc., and Biogen, Inc., for a ... the agreements, AstraZeneca will pay the largest sum, ...
(Date:7/7/2015)... , July 7, 2015 Sequent ... on developing innovative devices for the treatment of ... Kleine has joined its Board of Directors. ... years of medical device and healthcare industries experience. ... where he has commercialized numerous leading-edge products.  His ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... Bioness Inc. today announced that the company has ... further examine the impact of its NESS L300 wireless neurostimulation ... stroke. The FASTEST study aims to demonstrate the superiority of ... an ankle-foot orthosis (AFO), and has enrolled 176 patients at ...
... move that seeks to cut health care costs, create jobs, and ... awarded a grant worth up to $35 million over the next ... (NIPTE) to improve drug manufacturing standards. The grant comes ... to market in the U.S. exceeds $1 billion and an increasing ...
Cached Medicine Technology:Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study 2FDA Awards NIPTE Potential $35 Million in Grants to Reform Drug Manufacturing Process 2
(Date:7/7/2015)... ... 2015 , ... Today, the physicians at Allied Anesthesia, who provide services to ... Bernardino counties, released a series of tips to help children stay safe over the ... who spend more unsupervised time outdoors. , The most common causes of injuries ...
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a wearable startup ... first line of luxury smart jewelry called the Socialite™ collection. The product line ... fall. , “The Socialite collection was crafted to inspire women to be ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... growth strategy expert Jay Warden as Senior Vice President, heading the firm’s Healthcare ... to provide the best solutions to healthcare providers’ needs in ways that strengthen ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed ... stressful days at work is knowing that there is hopefully a vacation to look ... free as imagined. Planning for a vacation can be quite stressful, and it’s difficult ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3
... Ormond Street Hospital have developed a way of testing the ... known that very young children have a problem in breathing ... function tests. ,The researchers have devised a method ... of five years. The test was presented at the launch ...
... Seven women doctors have been suspended for their alleged ... sting operation beamed yesterday. // ,The doctors ... (Kota), Priyanaka Saxena (Sawaimadhopur), Madhu Mathur (Jhalawar), Rajkumar Choudhary ... on "awaiting posting order" and asked to report to ...
... Sun Pharmaceutical Industries Ltd today said it has allotted 61,716 ... into equity shares by FCCB holders. // ,The ... equity shares of Rs five each of the company at ... FCCBs of 1000 dollar each, the company informed the Bombay ...
... has revealed that only about 50% of the people are ... Mater Hospital in North Dublin. ,Nearly 4 among ... stance that the new hospital comes up at Mater. There ... wrong note, and now the opposition parties have requested the ...
... An analysis of records of pancreatic surgery during the ... by pancreatic cancer surgeon// Charles J. Yeo, M.D., Samuel ... Medical College of Thomas Jefferson University and Thomas Jefferson ... and his colleagues have revealed that contrary to what ...
... intestinal surgery, including stomach reduction for obesity, may increase ... of the study have been published in the British ... on three patients with increasingly poor eyesight or night ... space of a year. None of the patients had ...
Cached Medicine News:Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 3
... The NIDEK YC-1800 is an ... laser delivery and output technologies, improved ... offset and compact design with versatility ... YC-1800 replaces the YC-1600 and adds ...
... have an integrated filter made of ... This filter provides protection against carryover ... it does not swell up as ... can then be recovered easily. In ...
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
... • V-shaped bottom allows easy ... lips facilitate pour-out ,• Nesting ring ... Solution Basin designed for 4, 8, and ... V-shaped bottom permits withdrawal of practically all ...
Medicine Products: